Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and hemodynamics in patients with pulmonary arterial hypertension: Results of a double blind, randomized, placebo-controlled trial

被引：0
|
作者：
Channick, RN
Rubin, LJ
Simonneau, G
Robbins, I
Tapson, V
Frost, A
Badesch, DB
Bodin, F
Roux, SP
机构：
[1] Univ Calif San Diego, Ctr Med, San Diego, CA 92103 USA
[2] Hop Antoine Beclere, Clamart, France
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[7] Actelion, Allschwil, Switzerland
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
476
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension
    Badesch, DB
    Bodin, F
    Channick, RN
    Frost, A
    Rainisio, M
    Robbins, IM
    Roux, S
    Rubin, LJ
    Simonneau, G
    Sitbon, O
    Tapson, VF
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (04): : 227 - 246
  • [2] Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension
    Hatano, Masaru
    Yamada, Hidehiro
    Fukuda, Keiichi
    Yoshioka, Koichiro
    Funauchi, Masanori
    Kuwana, Masataka
    Sata, Masataka
    Taniguchi, Mitsugu
    Nakanishi, Norifumi
    Saito, Takefumi
    Saji, Tsutomu
    Sasayama, Shigetake
    HEART AND VESSELS, 2015, 30 (06) : 798 - 804
  • [3] Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension
    Masaru Hatano
    Hidehiro Yamada
    Keiichi Fukuda
    Koichiro Yoshioka
    Masanori Funauchi
    Masataka Kuwana
    Masataka Sata
    Mitsugu Taniguchi
    Norifumi Nakanishi
    Takefumi Saito
    Tsutomu Saji
    Shigetake Sasayama
    Heart and Vessels, 2015, 30 : 798 - 804
  • [4] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
    Channick, RN
    Simonneau, G
    Sitbon, O
    Robbins, IM
    Frost, A
    Tapson, VF
    Badesch, DB
    Roux, S
    Rainisio, M
    Bodin, F
    Rubin, LJ
    LANCET, 2001, 358 (9288): : 1119 - 1123
  • [5] Bosentan improves hemodynamics in patients receiving background sildenafil treatment: Results from early, a randomized, double-blind, placebo-controlled study in patients with mildly symptomatic pulmonary arterial hypertension
    Rubin, Lewis J.
    Simonneau, Gerald
    Hoeper, Marius M.
    Jansa, Pavel
    Kusic-Pajic, Andjela
    Galie, Nazzareno
    CHEST, 2007, 132 (04) : 487S - 487S
  • [6] Anastrozole in Pulmonary Arterial Hypertension A Randomized, Double-Blind, Placebo-controlled Trial
    Kawut, Steven M.
    Archer-Chicko, Christine L.
    DeMichele, Angela
    Fritz, Jason S.
    Klinger, James R.
    Ky, Bonnie
    Palevsky, Harold I.
    Palmisciano, Amy J.
    Patel, Mamta
    Pinder, Diane
    Propert, Kathleen J.
    Smith, K. Akaya
    Stanczyk, Frank
    Tracy, Russell
    Vaidya, Anjali
    Whittenhall, Mary E.
    Ventetuolo, Corey E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (03) : 360 - 368
  • [7] Breathe-5:: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology
    Galiè, N
    Beghetti, M
    Gatzonlis, N
    Granton, J
    Berger, R
    Lauer, A
    Chiossi, E
    Landzberg, M
    CHEST, 2005, 128 (04) : 496S - 496S
  • [8] BREATHE-1 results of a multicenter, randomized, double-blind, placebo-controlled study of bosentan in pulmonary arterial hypertension (PAH)
    Rubin, LJ
    Simonneaux, G
    Barst, RJ
    Gahe, N
    Badesch, DB
    Black, C
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S266 - S266
  • [9] Hemodynamic effects of sildenafil citrate in patients with pulmonary arterial hypertension: Results of a multicenter, international, randomized, double blind, placebo-controlled trial
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 9A - 10A
  • [10] Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertension
    Sasayama, S
    Kunieda, T
    Tomoike, H
    Matsuzaki, M
    Shirato, K
    Kuriyarna, T
    Izurni, T
    Origasa, H
    van Giersbergen, PL
    Dingemanse, J
    Tanaka, S
    CIRCULATION JOURNAL, 2005, 69 (02) : 131 - 137
12345